Soleus Capital Management as of Dec. 31, 2020
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 65 positions in its portfolio as reported in the December 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Spdr Ser Tr S&p Biotech Put Option (XBI) | 60.2 | $398M | 2.8M | 140.78 | |
Bioatla (BCAB) | 5.4 | $36M | 1.1M | 34.01 | |
Essa Pharma Com New (EPIX) | 4.3 | $28M | 2.4M | 11.93 | |
Iveric Bio | 1.7 | $11M | 1.6M | 6.91 | |
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.5 | $10M | 742k | 13.49 | |
C4 Therapeutics Com Stk (CCCC) | 1.3 | $8.9M | 269k | 33.13 | |
Ionis Pharmaceuticals Note 0.125%12/1 (Principal) | 1.3 | $8.7M | 8.5M | 1.02 | |
Xenon Pharmaceuticals (XENE) | 1.3 | $8.6M | 558k | 15.38 | |
Galecto (GLTO) | 1.2 | $8.1M | 650k | 12.51 | |
Exelixis (EXEL) | 1.2 | $7.8M | 391k | 20.07 | |
Natera (NTRA) | 1.1 | $7.4M | 74k | 99.52 | |
Vericel (VCEL) | 1.1 | $7.3M | 237k | 30.88 | |
Inhibrx | 1.1 | $7.0M | 214k | 32.97 | |
Iradimed (IRMD) | 1.0 | $6.9M | 304k | 22.80 | |
Tcr2 Therapeutics Inc cs | 0.9 | $6.2M | 200k | 30.93 | |
Dariohealth Corp Com New (DRIO) | 0.9 | $5.7M | 402k | 14.29 | |
Mersana Therapeutics (MRSN) | 0.8 | $5.5M | 207k | 26.61 | |
Silverback Therapeutics (SPRY) | 0.8 | $5.0M | 108k | 46.34 | |
Vesper Healthcare Acqstn Cor Com Cl A | 0.7 | $4.7M | 417k | 11.31 | |
Novocure Ord Shs (NVCR) | 0.7 | $4.3M | 25k | 173.05 | |
Oaktree Acquisition Corp Shs Cl A | 0.6 | $4.1M | 282k | 14.60 | |
SurModics (SRDX) | 0.6 | $4.0M | 93k | 43.52 | |
Misonix | 0.6 | $3.8M | 301k | 12.50 | |
Astrazeneca Sponsored Adr (AZN) | 0.5 | $3.2M | 64k | 50.00 | |
Dex (DXCM) | 0.5 | $3.0M | 8.2k | 369.63 | |
Alexion Pharmaceuticals | 0.4 | $3.0M | 19k | 156.25 | |
Itamar Med Sponsored Ads | 0.4 | $2.8M | 141k | 19.86 | |
Establishment Labs Holdings Ord (ESTA) | 0.4 | $2.5M | 67k | 37.64 | |
Gossamer Bio Note 5.000% 6/0 (Principal) | 0.4 | $2.5M | 2.8M | 0.90 | |
Neogenomics Com New (NEO) | 0.4 | $2.5M | 46k | 53.84 | |
Rafael Hldgs Com Cl B (RFL) | 0.4 | $2.4M | 105k | 23.32 | |
Merck & Co (MRK) | 0.4 | $2.3M | 28k | 81.81 | |
Turning Point Therapeutics I | 0.4 | $2.3M | 19k | 121.86 | |
Abbvie (ABBV) | 0.3 | $2.3M | 22k | 107.14 | |
Eiger Biopharmaceuticals | 0.3 | $2.3M | 186k | 12.29 | |
Compass Pathways Sponsored Ads (CMPS) | 0.3 | $2.0M | 43k | 47.63 | |
Oncorus | 0.3 | $1.8M | 56k | 32.33 | |
Provention Bio | 0.3 | $1.8M | 106k | 16.94 | |
Mirati Therapeutics | 0.3 | $1.7M | 7.8k | 219.70 | |
Oak Street Health | 0.3 | $1.7M | 28k | 61.17 | |
Nevro (NVRO) | 0.3 | $1.7M | 9.6k | 173.12 | |
Crispr Therapeutics Namen Akt (CRSP) | 0.3 | $1.7M | 11k | 153.07 | |
Trillium Therapeutics Com New | 0.2 | $1.5M | 104k | 14.71 | |
Adverum Biotechnologies | 0.2 | $1.5M | 136k | 10.84 | |
Kadmon Hldgs | 0.2 | $1.4M | 336k | 4.15 | |
Miragen Therapeutics Com New | 0.2 | $1.3M | 81k | 16.44 | |
Pieris Pharmaceuticals | 0.2 | $1.3M | 500k | 2.50 | |
Scholar Rock Hldg Corp (SRRK) | 0.2 | $1.2M | 25k | 48.52 | |
Zymeworks | 0.2 | $1.1M | 23k | 47.28 | |
Cardiff Oncology (CRDF) | 0.2 | $1.0M | 57k | 17.99 | |
Biogen Idec (BIIB) | 0.1 | $955k | 3.9k | 244.93 | |
Horizon Therapeutics Pub L SHS | 0.1 | $926k | 13k | 73.17 | |
Revance Therapeutics (RVNC) | 0.1 | $882k | 31k | 28.33 | |
Medicenna Therapeutics Corp. (MDNAF) | 0.1 | $874k | 187k | 4.68 | |
Lyra Therapeutics (LYRA) | 0.1 | $845k | 74k | 11.40 | |
Kymera Therapeutics (KYMR) | 0.1 | $813k | 13k | 61.99 | |
Biohaven Pharmaceutical Holding | 0.1 | $657k | 7.7k | 85.76 | |
Krystal Biotech (KRYS) | 0.1 | $625k | 10k | 59.96 | |
Fate Therapeutics (FATE) | 0.1 | $621k | 6.8k | 90.92 | |
Axogen (AXGN) | 0.1 | $605k | 34k | 17.89 | |
Alpine Immune Sciences | 0.1 | $517k | 41k | 12.59 | |
Protara Therapeutics Com Stk (TARA) | 0.1 | $390k | 16k | 24.23 | |
Oaktree Acquisition Corp *w Exp 99/99/999 | 0.1 | $358k | 92k | 3.90 | |
Invitae (NVTAQ) | 0.0 | $294k | 7.0k | 41.86 | |
Staar Surgical Com Par $0.01 (STAA) | 0.0 | $261k | 3.3k | 79.09 |